Rochelle Maney - Feb 23, 2024 Form 4/A Insider Report for ARTIVION, INC. (AORT)

Role
VP, Quality
Signature
/s/ Rochelle Maney
Stock symbol
AORT
Transactions as of
Feb 23, 2024
Transactions value $
-$46,259
Form type
4/A
Date filed
3/14/2024, 08:33 PM
Date Of Original Report
Feb 28, 2024
Previous filing
Feb 22, 2024
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Award $0 +3.37K +9.09% $0.00 40.4K Feb 23, 2024 Direct F1
transaction AORT Common Stock Sale -$23.7K -1.17K -2.89% $20.27 39.2K Feb 26, 2024 Direct F2, F3
transaction AORT Common Stock Award $0 +6.42K +16.37% $0.00 45.6K Feb 23, 2024 Direct F3, F4
transaction AORT Common Stock Sale -$22.6K -1.11K -2.44% $20.27 44.5K Feb 26, 2024 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
F2 These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,185 shares were sold, when in fact, 1,168 shares were sold.
F3 As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
F4 Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.
F5 These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,130 shares were sold, when in fact, 1,114 shares were sold.